GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,888,000 | +92.7% | 78,523 | +16.3% | 0.03% | +61.9% |
| Q4 2020 | $980,000 | +13.8% | 67,491 | +9.8% | 0.02% | -22.2% |
| Q3 2020 | $861,000 | +8.4% | 61,495 | +5.2% | 0.03% | -3.6% |
| Q2 2020 | $794,000 | +402.5% | 58,442 | +50.4% | 0.03% | +300.0% |
| Q1 2020 | $158,000 | -4.8% | 38,865 | +11.4% | 0.01% | +16.7% |
| Q4 2019 | $166,000 | +2.5% | 34,881 | +29.9% | 0.01% | 0.0% |
| Q3 2019 | $162,000 | -4.1% | 26,857 | +1.1% | 0.01% | +20.0% |
| Q2 2019 | $169,000 | +503.6% | 26,555 | +384.6% | 0.01% | +150.0% |
| Q1 2018 | $28,000 | +27.3% | 5,480 | +14.3% | 0.00% | 0.0% |
| Q4 2017 | $22,000 | -45.0% | 4,796 | +16.6% | 0.00% | -33.3% |
| Q3 2017 | $40,000 | -9.1% | 4,112 | +9.8% | 0.00% | -25.0% |
| Q2 2017 | $44,000 | -22.8% | 3,744 | -15.5% | 0.00% | -90.5% |
| Q1 2016 | $57,000 | – | 4,429 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versor Investments LP | 2,664,831 | $63,689,000 | 3.80% |
| Chicago Capital Management, LLC | 318,113 | $7,603,000 | 3.54% |
| First Trust Capital Management L.P. | 564,758 | $13,498,000 | 2.64% |
| WATER ISLAND CAPITAL LLC | 1,693,162 | $40,467,000 | 2.47% |
| Sand Grove Capital Management LLP | 992,068 | $23,710,000 | 2.31% |
| EMC Capital Management | 121,023 | $2,892,000 | 2.06% |
| OMNI PARTNERS LLP | 1,540,671 | $36,822,000 | 1.82% |
| TIG Advisors, LLC | 1,774,849 | $42,419,000 | 1.60% |
| Cowen Prime Services LLC | 174,850 | $4,179,000 | 1.58% |
| G2 Investment Partners Management LLC | 396,400 | $9,474,000 | 1.50% |